| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Mar 27, 2024 | Option Exercise | $83.34 | 16,610 | 1,384,277 | 207,361 | Mar 27, 2024, 08:50 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $85.22 | 20,093 | 1,712,325 | 192,304 | Mar 04, 2024, 07:50 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Jan 03, 2024 | Option Exercise | $17.40 | 49,122 | 854,723 | 209,602 | Jan 04, 2024, 09:35 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Jan 04, 2024 | Sale | $18.23 | 28,872 | 526,242 | 195,730 | Jan 04, 2024, 09:35 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Apr 17, 2023 | Sale | $16.53 | 15,000 | 248,025 | 156,779 | Apr 18, 2023, 07:07 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Apr 11, 2023 | Option Exercise | $11.63 | 112,590 | 1,309,296 | 205,574 | Apr 13, 2023, 05:13 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Apr 12, 2023 | Sale | $12.00 | 83,088 | 996,818 | 190,823 | Apr 13, 2023, 05:13 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Mar 30, 2023 | Sale | $12.95 | 224,779 | 2,911,303 | 278,807 | Apr 03, 2023, 07:24 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Apr 03, 2023 | Sale | $15.09 | 116,988 | 1,765,843 | 178,689 | Apr 03, 2023, 07:24 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Dec 30, 2022 | Option Exercise | $9.40 | 19,697 | 185,152 | 139,031 | Jan 04, 2023, 06:25 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Jan 03, 2023 | Option Exercise | $8.52 | 23,933 | 203,909 | 205,765 | Jan 04, 2023, 06:25 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Jan 04, 2023 | Option Exercise | $8.42 | 20,708 | 174,361 | 185,057 | Jan 04, 2023, 06:25 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Jan 03, 2022 | Option Exercise | $4.88 | 3,097 | 15,113 | 91,806 | Jan 05, 2022, 07:13 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Jan 04, 2022 | Option Exercise | $4.62 | 8,835 | 40,818 | 136,304 | Jan 05, 2022, 07:13 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Sep 28, 2021 | Option Exercise | $6.50 | 2,306 | 14,989 | 94,485 | Sep 30, 2021, 05:43 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Jan 19, 2021 | Option Exercise | $6.68 | 808 | 5,397 | 89,751 | Jan 19, 2021, 06:25 PM | |
| VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Chief Financial Officer | Jan 04, 2021 | Option Exercise | $5.80 | 2,787 | 16,165 | 90,559 | Jan 06, 2021, 04:28 PM |
Menu